US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jun 30, 2016 (10 years ago)

Glipizide 2.5 mg Extended-release tablets, 30-count bottle, Rx Only, Manufactured By…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications: Glipizide 2.5 mg ER Tablets exceeded dissolution specification rates for the 10 hour testing point.

What was recalled

Glipizide 2.5 mg Extended-release tablets, 30-count bottle, Rx Only, Manufactured By: Patheon Pharmaceuticals Inc Cincinnati, OH 45237, NDC 00591-0900-30

Recalling firm
Actavis Inc
NDC code
00591-0900-30
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1457-2016

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Glipizide recalls

See all